Having trouble viewing this email? View in your browser.
ESCMID Logo

12 December 2017
WEEKLY NEWS

Dear colleagues,

The election for the ESCMID Executive Committee (EC) is now closed. Thank you for voting and selecting the future leadership of your society. We will announce the results on the ESCMID website and in a special newsletter later this week.

Best regards, your ESCMID communications editors

 

New guidelines director from 2018: Luigia Scudeller from Pavia

Luigia Scudeller, a clinical epidemiologist specialized in methodology will become the new ESCMID Guidelines Director from January 2018. Luigia Scudeller’s main fields of interest are the design, implementation, analysis and publication of observational studies and clinical trials as well as the development of consensus documents and guidelines. Luigia Scudeller, who has a clinical background in infectious diseases, works at the Policlinic San Matteo Foundation in Pavia, Italy. She is succeeding William Hope, who stepped down from the ESCMID guideline director position to focus on his work as head of the Antimicrobial Pharmacodynamics and Therapeutics Group at the University of Liverpool. We thank William Hope for his valuable work for the society, and we welcome Luigia Scudeller as guidelines director and ad-hoc member of the Executive Committee.

› Read more
 

CMI highlight: EUCAST recommends not to trust gradient tests for colistin AST

Experts of the European Committee on antimicrobial susceptibility testing (EUCAST) evaluated five commercially available broth microdilution (BMD) products and two brands of gradient tests to determine the minimum inhibitory concentration (MIC) of colistin for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter spp. The colistin BMD products correlated well with reference tests, while gradient tests generally underestimated the lowest concentration of colistin inhibiting bacterial growth, resulting in a significant number of false susceptible results. Based on these results, EUCAST experts advise laboratories not to trust gradient tests for colistin susceptibility testing and to use broth microdilution methods for this purpose (open-access paper).

› Read more
 

Registration open for March 2018 adult immunization course in Brazil

The ESCMID postgraduate education course Adult Immunization: New and Old Challenges from 16 – 17 March 2018 in Sao Paulo, Brazil is co-organized with the Brazilian Society of Infectious Diseases (SBI) and the Brazilian Immunization Society (SBIM). Experts will discuss different aspects related to immunization in adults. Participants will learn about the importance and challenges of adult immunization, immune response in the elderly and vaccine schedule for adults, immunocompromised patients, healthcare workers and travellers. The course targets infectious disease, public health and travel health specialists, training physicians in infectious diseases, vaccinology and paediatrics as well as healthcare professionals interested in adult immunization.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.